Medical Safety Executive, Pharmacovigilance Department at COD Research Pvt. Ltd. (2026-04 – Present)
Promoted from Medical Safety Associate in recognition of consistent performance, regulatory accuracy, and cross-functional collaboration
- Authoring and reviewing US-PADER aggregate safety reports across multiple client portfolios spanning diverse therapeutic areas, maintaining 100% on-time regulatory submission compliance
- Leading development and review of signal management reports, enabling early identification of potential safety signals through integrated data analysis and literature review to strengthen client risk-benefit assessments
- Contributing to PSUR/PBRER authoring and review, ensuring alignment with ICH-E2 periodic safety update reporting requirements and internal quality standards
- Conducting systematic literature surveillance and regulatory intelligence screening, ensuring new safety information is captured within mandated reporting timelines
- Building and maintaining accurate line listings using MS Excel and PvEDGE Safety Database, and supporting a data migration initiative from the Argus Safety platform, improving data traceability and audit readiness across client accounts
- Supporting SOP development and inspection-readiness initiatives, contributing to zero major findings during internal quality reviews
- Coordinating with cross-functional regulatory, clinical, and quality teams across multiple client engagements to ensure consistent compliance tracking
Medical Safety Associate, Pharmacovigilance Department at COD Research Pvt. Ltd. (2024-07 – 2026-03)
- Authored and reviewed US-PADER aggregate safety reports across multiple client portfolios spanning diverse therapeutic areas, maintaining 100% on-time regulatory submission compliance
- Led development and review of signal management reports, enabling early identification of potential safety signals through integrated data analysis and literature review to strengthen client risk-benefit assessments
- Contributed to PSUR/PBRER authoring and review, ensuring alignment with ICH-E2 periodic safety update reporting requirements and internal quality standards
- Conducted systematic literature surveillance and regulatory intelligence screening, ensuring new safety information was captured within mandated reporting timelines
- Built and maintained accurate line listings using MS Excel and PvEDGE Safety Database, and supported a data migration initiative from the Argus Safety platform, improving data traceability and audit readiness across client accounts
- Supported SOP development and inspection-readiness initiatives, contributing to zero major findings during internal quality reviews
- Coordinated with cross-functional regulatory, clinical, and quality teams across multiple client engagements to ensure consistent compliance tracking
Clinical Pharmacist (Internship) at Apollo Hospitals International (2023-07 – 2024-06)
- Proactively identified, assessed, and documented adverse drug reactions (ADRs) and drug interaction risks through clinical pharmacy review, applying causality-assessment principles consistent with pharmacovigilance practice
- Delivered medication therapy management (MTM) and patient counselling to inpatients, supporting safe medication use across high-acuity hospital units
- Implemented antibiotic stewardship practices, contributing to optimized antimicrobial use, reduced inappropriate prescribing, and improved quality of patient safety data
- Administered IV therapy and supported inpatient care protocols in coordination with multidisciplinary clinical teams, reinforcing a strong foundation in patient safety monitoring
Science Faculty (Part-time) at Keystone Universe of Education (2023-07 – 2024-06)
- Delivered subject instruction emphasizing critical thinking and laboratory skills, applying structured classroom management techniques
